CAP IASLC AMP MOLECULAR TESTING GUIDELINE

Posted by Samantha Powell on April 3rd, 2013 | No comments

IASLC

CAP IASLC AMP MOLECULAR TESTING GUIDELINE

The IASLC, the College of American Pathologists (CAP), and the Association for Molecular Pathology (AMP) have developed an evidence-based guideline, “Molecular Testing Guideline for the Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors,” which establishes standards for EGFR and ALK testing, helping to guide targeted therapies. The guideline was released April 3, 2013, in Archives of Pathology & Laboratory Medicine, the Journal of Thoracic Oncology, and the Journal of Molecular Diagnostics.

READ MORE

Comments are closed.